Global /China /Healthcare /Biotechnology /688687

Beijing Kawin Technology Share-Holding Co., Ltd.

688687

• SSE: 688687 • Delayed

19.76CNY -1.5%

2.92 USD

As of 17 June 2026, Beijing Kawin Technology Share-Holding Co., Ltd. has a market cap of $488.6M USD, ranking #15314 globally and #4784 in China. It ranks #1362 in the Healthcare sector, and #263 in the Biotechnology industry.

Global Rank

15314

Country Rank

4784

Sector Rank

1362

Industry Rank

263

Key Stats

Market Cap

$488.6MUSD

3.31B CNY

Enterprise Value

$407.02MUSD

2.75B CNY

Revenue (TTM)

$191.4MUSD

1.3B CNY

EBITDA (TTM)

$32.65MUSD

220.98M CNY

Net Income (TTM)

$1.63MUSD

11.06M CNY

EBITDA Margin

17%

Profit Margin

0.9%

PE Ratio

295.7

Forward PE

16.0

PS Ratio

2.6

PB Ratio

1.9

EV/EBITDA

12.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Desheng Zhou open_in_new

Employees

600

Founded

2008

Website

kawin.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.5%	-4.8%	-2.3%	-10%	-30%	-21%	-20%	-30%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688687 北京凯因科技股份有限公司 Class A ISIN: CNE1000054C3 Shares Out.: Shares Outstanding: 167.435M¹ Shares Float: 167.424M² TV: TradingView: SSE: 688687 SA: Stock Analysis: SHA: 688687 YF: Yahoo Finance: 688687.SS GF: Google Finance: SHA: 688687 BA: Barron's: 688687 MS: Morningstar: XSHG: 688687	19.76 CNY	TV: TradingView: SSE: 688687 SA: Stock Analysis: SHA: 688687 YF: Yahoo Finance: 688687.SS GF: Google Finance: SHA: 688687 BA: Barron's: 688687 MS: Morningstar: XSHG: 688687

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Beijing Kawin Technology Share-Holding Co., Ltd.

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manufacture organization/contract development and manufacturing organization; technology and biotechnology development; technical consulting; biotechnology consulting; science and technology promotion and application; and wholesale of medical supplies. Beijing Kawin Technology Share-Holding Co., Ltd. was incorporated in 2008 and is based in Beijing, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 3K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 2K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.01B 54.23B CNY 2K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.34B 49.69B CNY 1K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 1K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 1K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 37K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 33K%	19.0	United States
argenx SE EBR: ARGX	$47.99B 41.39B EUR 10K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$45.02B 68.19T KRW 9K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.64B 60.27B AUD 9K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.46B 33.71B CHF 9K%	37.2	Switzerland

chevron_leftBack